MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease
VIB-KU Leuven Center for Brain & Disease Research · Ikerbasque · +10 more institutions
Abstract
Neuronal cell loss is a defining feature of Alzheimer’s disease (AD), but the underlying mechanisms remain unclear. We xenografted human or mouse neurons into the brain of a mouse model of AD. Only human neurons displayed tangles, Gallyas silver staining, granulovacuolar neurodegeneration (GVD), phosphorylated tau blood biomarkers, and considerable neuronal cell loss. The long noncoding RNA MEG3 was strongly up-regulated in human neurons . This neuron-specific long noncoding RNA is also up-regulated in AD patients. MEG3 expression alone was sufficient to induce necroptosis in human neurons in vitro. Down-regulation of MEG3 and inhibition of necroptosis using pharmacological or genetic manipulation of…
Citation impact
- FWCI
- 48.70
- Percentile
- 100%
- References
- 70
Authors
18- SBSriram BalusuCorresponding
VIB-KU Leuven Center for Brain & Disease Research
- KHKatrien Horré
VIB-KU Leuven Center for Brain & Disease Research
- NTNicola Thrupp
VIB-KU Leuven Center for Brain & Disease Research
- KCKatleen Craessaerts
VIB-KU Leuven Center for Brain & Disease Research
- ASAn Snellinx
VIB-KU Leuven Center for Brain & Disease Research
Topics & keywords
- Necroptosis
- Neurodegeneration
- Biology
- Cell biology
- Kinase
- Programmed cell death
- Neuron
- Human brain
Funding
- AAAlzheimer's AssociationAwards: ADSF-21-831377-C, -21-850325, 21-831377-C, ADSF-21-831376-C, 850325, AARG-21-, ADSF-21-831381-C, AARF-21-850325
- ADAlzheimer's Drug Discovery FoundationAward: 201809-2016862
- BFBrightFocus FoundationAward: A2020812F
- FEFamiljen Erling-Perssons StiftelseAwards: FO2019-0228, 860197
- GOGun och Bertil Stohnes Stiftelse
- DDemensförbundet
- SFStiftelsen för Gamla TjänarinnorAwards: 860197, FO2019-0228
- EJEU Joint Programme – Neurodegenerative Disease ResearchAward: JPND2021-00694
- URUK Research and InnovationAward: MR/Y014847/1
- ECEuropean CommissionAwards: 13039/501100011033, 501100011033, 681712, 860197, JPND2021-00694
- ZZonMw
- EJEusko Jaurlaritza
- FWFonds Wetenschappelijk OnderzoekAward: 12P5922N
- HHjärnfondenAwards: FO2019-0228, FO2020-0240
- KLKU Leuven
- VVetenskapsrådetAwards: 2021-03244, 681712, 2018-, 2018-02532
- AAlzheimerfondenAward: AF-930627
- ISInternational Society for Neurochemistry
- ANAlzheimer Nederland
- VRVlaamse regering
- DDemensfonden
- PParkinsonfonden
- MRMedical Research CouncilAward: MR/Y014847/1
- RRIKEN
- AEAgencia Estatal de InvestigaciónAwards: 501100011033, 13039, AEI/10, 13039/501100011033
- RBRIKEN Brain Science Institute